On January 20, shares of Applied Molecular Transport Inc. (AMTI) fell further deep in the after-hours session. No official news is behind the fall of the stock.
During regular trading, the stock varied between a high of $10.28 and a low of $9.26. AMTI closed the session at $9.31 with a loss of 3.82% at a volume of 279.7K shares. The stock suffered a further loss of 8.70% in the after-hours at $8.50.
The clinical-stage biopharmaceutical company, Applied Molecular Transport Inc. was founded in 2016. Currently, the company has a market capitalization of $372.58 million with 38.49 million outstanding shares.
AMTI Stock Movement
Since the start of the new year, AMTI stock has been in a continuous downtrend with the exception of a slight gain on January 07. The stock started the year 2022 at $14.17 and has since declined to reach its 52-week low of $9.26 in Thursday’s regular session. The stock plunged further below the 52-week low to reach $8.50 in the after hours. Consequently, the stock has lost a huge 33.40% year to date and 17.76% in the past five days alone. Moreover, AMTI also suffered a loss of 74.31% last year.
While there is no recent announcement or SEC filing from the company, the stock has been all but going down. Although the stock’s overall movements depict a picture in red, there is still hope for some recovery. Given the fall well below its 52-week low, AMTI stock might gain the interest of some investors as a good buying opportunity. Only the upcoming trading session will show if it will recover or fall further down.
AMTI’s Participations and Events
On November 18, the company participated in the Virtual Jefferies London Healthcare Conference. The company’s Chief Medical Officer, Bittoo Kanwar, and Chief Business and Strategy Officer, Liz Bhatt participated in a fireside chat during the conference.
Previously, AMTI held Research & Development Day on October 15, 2021. Moreover, key IBD and rheumatology opinion leaders, Brian Feagan, MD, and Peter Lipsky, MD also participated in AMTI management’s virtual meeting on the day.
Q3 Financial Data
On November 10, the company declared its third-quarter financial results for 2021.
In the third quarter of 2021, AMTI had a net loss of $26.0 million, against $16.8 million in Q3 of 2020.
Furthermore, the company ended the quarter with cash, cash equivalents, and investments of $182.5 million.
